NCT02677051View on ClinicalTrials.gov

Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions
AutismAutistic DisorderAutism Spectrum DisorderAutistic Behavior
Interventions
DRUG

Sulforaphane

Sulforaphane (1-isothiocyanato-4R- (methylsulfinyl)butane) is an isothiocyanate derived from the action of the plant enzyme myrosinase on glucosinolates including glucoraphanin and comes from consumption of many cruciferous vegetables.

DRUG

Placebo

Trial Locations (1)

08854

Rutgers University - Staged Research Building, Piscataway

All Listed Sponsors
collaborator

Rowan University

OTHER

lead

Rutgers, The State University of New Jersey

OTHER